dextran 2-(diethylamino)ethyl ether
Small moleculeexperimental
Clinical trial activity
1 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2022 (NCT06030297)
Timeline
No events for the selected filters.
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL2108241 ↗
Also known as
- colextran
- colextran
- colextran
- colextran
- colextran hcl
- colextran hydrochloride
- dextran 2-(diethylamino)ethyl ether
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06030297 | N/A | Nov 1, 2022 | National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), Stanford University, University of Utah |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Institute of Neurological Disorders and Stroke (NINDS) | Government | 1 | 0 | 1 | 2022 |
| National Institutes of Health (NIH) | Government | 1 | 0 | 1 | 2022 |
| Stanford University | Academic/Hospital | 1 | 0 | 1 | 2022 |
| University of Utah | Academic/Hospital | 1 | 1 | 1 | 2022 |
4 organizations
Page 1 / 1